a clinical-stage biopharmaceutical company
Industry Biotechnology
A.I.dvisor indicates that over the last year, NERV has been loosely correlated with SYRE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then SYRE could also see price increases.
Ticker / NAME | Correlation To NERV | 1D Price Change % | ||
---|---|---|---|---|
NERV | 100% | -2.06% | ||
SYRE - NERV | 35% Loosely correlated | +1.58% | ||
MIST - NERV | 27% Poorly correlated | +1.31% | ||
OCUP - NERV | 27% Poorly correlated | +1.53% | ||
SWTX - NERV | 26% Poorly correlated | +0.45% | ||
ATOS - NERV | 24% Poorly correlated | -2.07% | ||
More |